Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jutzi, Susanne"'
Autor:
Schläfli, Anna M., Tokarchuk, Igor, Parejo, Sarah, Jutzi, Susanne, Berezowska, Sabina, Engedal, Nikolai, Tschan, Mario P.
Publikováno v:
Schläfli, Anna M. Tokarchuk, Igor Parejo, Sarah Jutzi, Susanne Berezowska, Sabina Engedal, Nikolai Tschan, Mario P. . ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells. Scientific Reports. 2021, 11(1), 1-11
Scientific Reports
Scientific Reports
Externí odkaz:
http://hdl.handle.net/10852/90946
https://www.duo.uio.no/bitstream/handle/10852/90946/1/s41598-021-87966-6.pdf
https://www.duo.uio.no/bitstream/handle/10852/90946/1/s41598-021-87966-6.pdf
Autor:
Schläfli, Anna M, Tokarchuk, Igor, Parejo, Sarah, Jutzi, Susanne, Berezowska, Sabina, Engedal, Nikolai, Tschan, Mario P.
Publikováno v:
Scientific Reports
Schläfli, Anna M; Tokarchuk, Igor; Parejo, Sarah; Jutzi, Susanne; Berezowska, Sabina; Engedal, Nikolai; Tschan, Mario P. (2021). ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells. Scientific reports, 11(1), p. 9011. Springer Nature 10.1038/s41598-021-87966-6
Scientific reports, vol. 11, no. 1, pp. 9011
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Schläfli, Anna M; Tokarchuk, Igor; Parejo, Sarah; Jutzi, Susanne; Berezowska, Sabina; Engedal, Nikolai; Tschan, Mario P. (2021). ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells. Scientific reports, 11(1), p. 9011. Springer Nature 10.1038/s41598-021-87966-6
Scientific reports, vol. 11, no. 1, pp. 9011
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
ALK inhibitors effectively target EML4-ALK positive non-small cell lung cancer, but their effects are hampered by treatment resistance. In the present study, we asked whether ALK inhibition affects autophagy, and whether this may influence treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3deb523d99078aac1330be6d51ca70cf
Autor:
Schläfli AM; Institute of Pathology, University of Bern, Bern, Switzerland. anna.schlaefli@pathology.unibe.ch., Tokarchuk I; Institute of Pathology, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Parejo S; Institute of Pathology, University of Bern, Bern, Switzerland., Jutzi S; Institute of Pathology, University of Bern, Bern, Switzerland., Berezowska S; Institute of Pathology, University of Bern, Bern, Switzerland.; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Engedal N; Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Tschan MP; Institute of Pathology, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Publikováno v:
Scientific reports [Sci Rep] 2021 Apr 27; Vol. 11 (1), pp. 9011. Date of Electronic Publication: 2021 Apr 27.
